Dr. Lastra is a surgical pathologist and cytopathologist with subspecialty focus in gynecologic pathology.
The Johns Hopkins Hospital
Advanced Specialty Training Program - Gynecologic Pathology
2015
Hospital of the University of Pennsylvania
Fellowship - Cytopathology
2014
Hospital of the University of Pennsylvania
Fellowship - Surgical Pathology
2013
Pennsylvania Hospital
Residency - Anatomic and Clinical Pathology
2012
Universidad Central de Venezuela
MD
2005
Utilization of Key Morphologic and Molecular Prognostic and Predictive Parameters in Endometrial Malignancies: A Survey of Gynecologic Pathologists.
Utilization of Key Morphologic and Molecular Prognostic and Predictive Parameters in Endometrial Malignancies: A Survey of Gynecologic Pathologists. Int J Surg Pathol. 2026 Aug; 34(5):1134-1145.
PMID: 41755714
Mammary-type Metaplastic Carcinoma Arising From Vulvar Hidradenoma Papilliferum: A Case Report.
Mammary-type Metaplastic Carcinoma Arising From Vulvar Hidradenoma Papilliferum: A Case Report. Int J Gynecol Pathol. 2026 Nov 01; 45(6):490-494.
PMID: 41744281
Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV status.
Survival comparison analysis between cervical squamous cell carcinoma and adenocarcinoma with a special focus on the HPV status. Gynecol Oncol. 2026 02; 205:89-98.
PMID: 41576549
Integration of cell-type resolved spatial proteomics and transcriptomics reveals novel mechanisms in early ovarian cancer.
Integration of cell-type resolved spatial proteomics and transcriptomics reveals novel mechanisms in early ovarian cancer. medRxiv. 2025 Aug 28.
PMID: 40909841
Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer.
Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer. Breast Cancer Res Treat. 2025 Oct; 213(3):347-354.
PMID: 40779028
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression.
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression. Cancer Cell. 2025 Aug 11; 43(8):1495-1511.e7.
PMID: 40578359
A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer.
A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer. Clin Cancer Res. 2025 Jun 03; 31(11):2230-2240.
PMID: 40145935
Adaptive immune response and PD-1/ PD-L1 status in chemotherapy treated high grade serous carcinoma is dependent on chemotherapy response score.
Adaptive immune response and PD-1/ PD-L1 status in chemotherapy treated high grade serous carcinoma is dependent on chemotherapy response score. Hum Pathol. 2025 May; 159:105800.
PMID: 40389122
Clinicopathologic and Molecular Characterization of Gynecologic Carcinosarcomas With a Mesonephric-Like Carcinomatous Component.
Clinicopathologic and Molecular Characterization of Gynecologic Carcinosarcomas With a Mesonephric-Like Carcinomatous Component. Am J Surg Pathol. 2025 05 01; 49(5):439-447.
PMID: 39931796
A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause.
A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause. Nat Commun. 2025 01 03; 16(1):372.
PMID: 39753552